Posted on

Breast Tissue Arrays

Need more information, quote or place an order?  Please email to: info@vitrovivo.com

 

SKU#

DESCRIPTION

CASE

CORE

Price ($)

BC08212Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores96100337.50
BR485Breast cancer and normal tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores4896517.50
BR20828Breast cancer survey tissue array (22 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208592.50
BR20831Breast cancer survey tissue array (25 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208592.50
BR20836Breast cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 208 cases/208 cores208208682.50
T089bBreast cancer tissue array (4x (2×3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T089c62460.00
BR1510Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores50150442.50
BR1202bBreast cancer tissue array (most of triple negative), including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing BR1202a60120442.50
BR1509aBreast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC marker (ER,PR,Her-2 and Ki-67), 50 cases/150 cores50150382.50
BR1201bBreast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a60120442.50
BR901Breast cancer tissue array (pathology grade 1-3), including TNM and clinical stage data, 45 cases/90 cores4590337.50
BR082aBreast cancer tissue array with Her-2 IHC (0-3+) control, including TNM and pathology grade, Her-2 status, 4 cases/8 cores, replaced by BR082b4897.50
BR1321Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 120 cases/ 132 cores120132592.50
BR251aBreast cancer tissue array with matched cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR25162460.00
BR251cBreast cancer tissue array with matched cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b62460.00
BRC051Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores5552.50
BR248aBreast cancer tissue array with normal tissue as control, including TNM and pathology grade, 24 cases/ 24 cores, replacing BR2482424135.00
BR483bBreast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR4834848277.50
BR483cBreast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR483b4848277.50
BR2088Breast cancer tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores104208592.50
BR727Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores2472382.50
BR728Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC080152472337.50
BR965Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC9624896315.00
BR501Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/ 50 cores5050337.50
BR1006bBreast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a50100382.50
BR1081Breast cancer tissue array, including pathology grade, TNM and clinical stage, 54 cases/108 cores54108382.50
BR641Breast cancer tissue array, including pathology grade, TNM and clinical stage, 64 cases/ 64 cores6464337.50
BR1505fBreast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e75150382.50
BR803bBreast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replaced by BR803c8080322.50
FISHBreast cancer tissue array, including pathology grade, TNM, clinical stage and Her-2 marker, 5 cases/5 cores5567.50
BR2089Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 104 cases/208 cores104208592.50
BR805Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores8080382.50
BR807Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores8080337.50
BR246Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246a122482.50
BR484bBreast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR484a4848382.50
BR1505cBreast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases/150 cores, replaced BR1505b75150382.50
FMG08013eBreast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC08013d7272382.50
FMG08013fBreast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e7272382.50
FBR-245bBreast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, replacing BR245a122482.50
BRE501Breast cancer with breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores5050202.50
BRE502Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 31 cases/50 cores5050202.50
BR2085cBreast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b188208682.50
FBR-087dBreast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c62482.50
T088eBreast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088d62482.50
BR1504cBreast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b75150382.50
BR251dBreast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c62460.00
BR1008aBreast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 96 cases/100 cores, replacing BR1008100100382.50
BR201Breast disease spectrum tissue array, including pathology grade, TNM and clinical stage, 20 cases/20 cores2020270.00
BR601aBreast fibroadenoma tissue array, 30 cases/ 60 cores, replacing BR6013060337.50
BR8010Breast fibroadenoma, breast tissue and breast cancer array, including pathology grade, TNM and clinical stage, 71 cases/80 cores7180382.50
PM2b-ERBreast invasive carcinoma tissue array, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores101060.00
PM2A-PRBreast invasive carcinoma tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores101097.50
BR8018Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC080148080322.50
BR802bBreast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47 cases/80 cores, replacing BR8024780322.50
BR401Breast mastitis tissue array, 20 cases/40 cores2040277.50
BR402Breast mastitis tissue array, 20 cases/40 cores2040277.50
BRN04Breast tissue array, 4 cases/4 cores44142.50
BR20832Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores208208682.50
BR20825Breast tumor survey tissue array (19 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 104 cases/208 cores104208592.50
BR20833Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores208208682.50
BR20830Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208592.50
BR20834Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores208208682.50
BR20835Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores208208682.50
BR20824Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores104208592.50
HER2cHer-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/ 10 cores, replacing Her2b101097.50
BR8017Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores8080322.50
BR351Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores353582.50
BRE1201Triple negative breast cancer and normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 120 cases/120 cores120120742.50
BRE1121Triple negative breast cancer with normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 112 cases/112 cores112112697.50
BR1003bMultiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a47101382.50
BR1003cMultiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003b47101382.50

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.